Ric Sinclair appointed CEO as Dr. Emad Rizk steps into Senior Advisor role
Cotiviti, a leader in enterprise healthcare software and data-driven technology solutions, today announced a strategic leadership transition designed to expand platform-led innovation, accelerate growth, and advance its mission to improve healthcare quality and efficiency. Seasoned healthcare executive Ric Sinclair will join the company as Chief Executive Officer and member of the Board of Directors, effective March 16, 2026. Emad Rizk, M.D., will transition from his role as CEO, President, and Chairman to Senior Advisor to the Board of Directors and Executive Team.
Dr. Rizk led Cotiviti through a decade of significant evolution, positioning the company as a recognized industry leader. Over his ten-year tenure, Cotiviti expanded its capabilities and market presence through several transformational acquisitions, laying the foundation for continued innovation, organic growth, and scalable operations. In partnership with Veritas and KKR, he oversaw the successful integration of Edifecs and advanced the combined company’s platform, strengthening interoperability and enhancing its ability to help payers and providers address quality gaps, cost pressures, and operational complexity.
“Leading Cotiviti has been a privilege,” said Dr. Rizk. “I am thankful for the dedication of the senior leadership team and the commitment of our owner-employees. Together, we built a resilient foundation and cultivated a culture built on respect and excellence, all supported by collaboration and purpose. I am confident the organization is well positioned to continue delivering meaningful impact across the healthcare ecosystem. With Ric Sinclair’s appointment as CEO, I believe his expertise and vision make him exceptionally qualified to guide Cotiviti into the next chapter, focused on supporting a more efficient and effective healthcare system.”
Ric joins Cotiviti from Waystar, where he served as Chief Business Officer and was instrumental in building and scaling a high-growth, enterprise-grade technology platform. His experience driving cutting-edge solution development, commercial product design, operational rigor, and sustainable value creation aligns closely with Cotiviti’s current strategy as it continues to expand its platform, scale its solutions, and deliver greater value to clients and partners.
“I’m excited to join Cotiviti at a defining moment in its journey,” said Sinclair. “With our exceptional team and solid foundation, we are uniquely positioned to shape the next era of healthcare innovation. My priority is to accelerate this transformation — unlocking efficiency, reducing complexity, and delivering measurable improvements across both medical and administrative challenges for all stakeholders in healthcare.”
“As a long-standing partner and investor in Cotiviti, we have witnessed the company’s remarkable journey firsthand,” said Ramzi Musallam, CEO and Managing Partner of Veritas. “We are delighted to support Cotiviti’s next phase under Ric Sinclair’s leadership and remain confident in the team’s ability to drive continued success. We express our deepest gratitude to Dr. Rizk for his insightful leadership and steadfast commitment. Under his guidance, Cotiviti has evolved into a dynamic organization, achieved remarkable results for its clients, and fostered a collaborative workplace that will leave a lasting positive impact on Cotiviti’s future achievements.”
“We are pleased to have Ric Sinclair join us in Cotiviti’s next chapter of growth,” said Max Lin, Partner at KKR. “Ric has a strong track record of advancing technology platforms, and we believe his product vision, operational discipline, and growth orientation will position the company for continued success. We extend our sincerest appreciation to Dr. Rizk for his exemplary leadership and unwavering dedication, which have been instrumental in building Cotiviti’s robust foundation and shaping the organization’s legacy.”
Through Cotiviti’s integrated technology platform, access to data, advanced analytics, and responsible AI deployment, the company remains focused on advancing healthcare technology, enhancing performance, and delivering enduring value for all stakeholders.